Clinical Trial Update: Assessment of the eFficacy, the Onset-of-Action and the Safety of Tot'héma® in Adults With Moderate Iron Deficiency Anaemia [Phase 4]

View source ↗

Summary

Phase 4 trial updating the efficacy, onset of action, and safety of Tot'héma in adults with moderate iron deficiency anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Tot'héma

Snippet

Sponsor: Laboratoire Innotech International | Conditions: Anemia | Phase 4 | Status: COMPLETED